Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JTE-907 is a CB2 receptor inverse agonist with high selectivity and oral activity.JTE-907 exhibits anti-inflammatory activity in vivo.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 51.00 | |
5 mg | In stock | $ 128.00 | |
10 mg | In stock | $ 197.00 | |
25 mg | In stock | $ 347.00 | |
50 mg | In stock | $ 516.00 | |
100 mg | In stock | $ 736.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 153.00 |
Description | JTE-907 is a CB2 receptor inverse agonist with high selectivity and oral activity.JTE-907 exhibits anti-inflammatory activity in vivo. |
In vitro | JTE 907 acts as a Gq-coupled agonist in islets to stimulate insulin secretion and maintain β-cell mass in a GPR55-independent fashion. JTE 907 (10 μM) significantly stimulated insulin secretion from islets isolated from human donors and islets from Gpr55+/+ and Gpr55-/- mice. These stimulatory effects were accompanied by significant elevations of IP1 and [Ca2+]i, but there were no changes in cAMP generation. JTE 907 also significantly reduced cytokine-induced apoptosis in human and mouse islets and promoted human β-cell proliferation.[4] |
Synonyms | JTE 907 |
Molecular Weight | 438.47 |
Formula | C24H26N2O6 |
CAS No. | 282089-49-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 112.5 mg/mL (256.6 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JTE-907 282089-49-0 GPCR/G Protein Cannabinoid Receptor JTE907 JTE 907 inhibitor inhibit